User Posts: admin3
0
Stand and deliver: why drug transport is more important than you think… – Cancer Research UK
0

A subset of broad specificity SLC transporter families, as well as ABC transporters such as ABCB1 (P-glycoprotein) and ABCG2 (BCRP), are well studied ...

0
Hydration and Movement Are Important for Patients With MPNs
0

Patients with myeloproliferative neoplasms (MPNs) — a group of blood cancers that causes the bone marrow to overproducer red or white blood cells or ...

0
Empowering Women of Color to Advocate for Best Breast Cancer Treatment
0

In part five of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black ...

0
Combination Immunotherapy for Treating Advanced Renal Cell Carcinoma
0

An overview of the treatment protocol for patients with advanced RCC who are receiving IO/TKI or IO/IO combination therapy.

0
Initial Treatment Options for Metastatic TNBC
0

Dr Noor Abuhadra discusses the various first-line treatment options for metastatic TNBC, highlighting the importance of PDL1 expression for immunotherapy ...

0
Second-Line Therapy for Metastatic TNBC
0

Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a ...

0
Patients with Gastrointestinal Cancers Face Inequities in End-Of-Life Pain Management Due to Race, Poverty
0

There are persistent racial and ethnicity-based inequities in end-of-life pain management, specifically affecting end-of-life access to and utilization of ...

0
To Improve Multiple Myeloma Survival, Diabetes Management Cannot Be Ignored
0

Researchers are advising that, in order to improve survival among patients with multiple myeloma, “(diabetes) management cannot be ignored,” according to ...

0
Was There a “Right Way” For Me To Heal After Cancer?
0

I’ll never forget how exhausting it was navigating treatment after my diagnosis with bone cancer.One crowd urged me to get started with chemotherapy as soon ...

0
Immunotherapy ‘Boosts’ May Improve Outcomes for Advanced Kidney Cancer
0

Opdivo (nivolumab), when given with or without Yervoy (ipilimumab) improved outcomes for patients with intermediate-risk and poor-risk clear-cell metastatic ...

User Deals: admin3
Browsing All Comments By: admin3
CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart